TMEM229B
Transmembrane protein 229B
Also known as: C14orf83, FLJ33387, T229B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBD8
- Gene
- TMEM229B
- Ensembl
- ENSG00000198133
- Chromosome
- 14
- Canonical length
- 167 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to act upstream of or within macrophage activation and response to bacterium. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
167 residues, UniProt reviewed canonical sequence.
>Q8NBD8|TMEM229B
1 MASAEPLTAL SRWYLYAIHG YFCEVMFTAA WEFVVNLNWK FPGVTSVWAL FIYGTSILIV
61 ERMYLRLRGR CPLLLRCLIY TLWTYLWEFT TGFILRQFNA CPWDYSQFDF DFMGLITLEY
121 AVPWFCGALI MEQFIIRNTL RLRFDKDAEP GEPSGALALA NGHVKTDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM229B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 25 nTPM
- adrenal gland: 14 nTPM
- cerebral cortex: 11 nTPM
- parathyroid gland: 11 nTPM
- duodenum: 10 nTPM
- hippocampal formation: 9.9 nTPM
Single-cell type
- cone photoreceptor cells: 89 nCPM
- thyrotrophs: 66 nCPM
- oligodendrocyte progenitor cells: 51 nCPM
- epididymal principal cells: 48 nCPM
- late spermatids: 48 nCPM
- corticotrophs: 39 nCPM
Immune cell
- gdT-cell: 6.9 nTPM
- eosinophil: 6.3 nTPM
- MAIT T-cell: 6.1 nTPM
- memory CD8 T-cell: 5.4 nTPM
- intermediate monocyte: 4.8 nTPM
- naive CD8 T-cell: 4.6 nTPM
Brain region
- pons: 42 nTPM
- cerebellum: 36 nTPM
- medulla oblongata: 28 nTPM
- cerebral cortex: 25 nTPM
- thalamus: 24 nTPM
- midbrain: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 1.69
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Putative ABC-transporter type IV CmpB/TMEM229
- Putative ABC-transporter type IV
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM229B as an antibody target. Whether an autoantibody or antibody against TMEM229B could matter depends on whether native TMEM229B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM229B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM229B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...